This fact can partially justify the under-expression of FBLN1 in 4 diseases of our transcriptomics analyses (even though it was over-expressed in IgG4-related Disease), since gene expression is measured by the level of the corresponding mRNA present in a cell. The gene discussed is FBLN1; the disease is immunoglobulin G4-related sclerosing disease.